TNG961
/ Tango Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 13, 2025
TNG961: A selective oral molecular glue degrader of HBS1L inducing tumor regression in naïve and PRMT5i-refractory FOCAD-deleted models
(AACR-NCI-EORTC 2025)
- "Notably, TNG961 remains effective in a pancreatic model that has become refractory to PRMT5 inhibitor treatment, supporting its potential utility in PRMT5i-resistant settings. TNG961 has been nominated as a development candidate and is currently in IND-enabling studies."
Oncology • CDKN2A • CDKN2B • CRBN • GSPT1 • MTAP • SALL4
1 to 1
Of
1
Go to page
1